Ultra-Rapid Lispro Efficacy and Safety Compared to Humalog® in Japanese Patients with Type 1 Diabetes: PRONTO-T1D Subpopulation Analysis
Crossref DOI link: https://doi.org/10.1007/s13300-020-00892-0
Published Online: 2020-07-29
Published Print: 2020-09
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Miura, Junnosuke
Imori, Makoto
Nishiyama, Hiroshi
Imaoka, Takeshi
Funding for this research was provided by:
Eli Lilly and Company
Eli Lilly Japan
Text and Data Mining valid from 2020-07-29
Version of Record valid from 2020-07-29
Article History
Received: 27 March 2020
First Online: 29 July 2020